Novo Nordisk Science

For US Healthcare Professionals

This site provides U.S. healthcare professionals with scientific information on unapproved uses of approved or cleared medical products. All information is intended to be non-promotional in nature, scientifically sound, and shared in line with FDA guidance. Please consult full prescribing information before making any clinical practice decisions for the care and management of individual patients. 

The presentations below were developed by Novo Nordisk Inc. and must be viewed with the provided source publication that is the subject of the corresponding presentation.

NovoSeven® RT

Website

NovoSeven® RT SIUU Disclosures

Website

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia

Website

Prescribing Information

Continue
Continue